CIGB-258
CIGB-258 Uses, Dosage, Side Effects, Food Interaction and all others data.
CIGB-258 is a peptide that is immunoregulatory and derived from heat shock protein 60 of the cellular variant. As of 2020, The Center for Genetic Engineering and Biotechnology (CIGB) in Havana, Cuba, is testing the treatment efficacy of this peptide in patients with COVID-19 who are under intensive therapy regimens (RPCEC00000313).
| Trade Name | CIGB-258 |
| Generic | CIGB-258 peptide |
| CIGB-258 peptide Other Names | CIGB-258 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here CIGB-258
